Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dexcom
MedTech
FDA clears Dexcom's basal dosing software for Type 2 diabetes
Dexcom said Smart Basal is the first CGM-integrated application in Type 2 diabetes for people taking a glargine U-100 long-acting insulin.
Conor Hale
Nov 19, 2025 9:45am
Dexcom hit by FDA Class I recall for its CGM system app
Nov 5, 2025 8:45am
Dexcom CEO goes on leave while Insulet taps new CFO
Sep 17, 2025 12:15pm
Dexcom CEO Kevin Sayer to pass torch to COO Jake Leach
Jul 31, 2025 11:00am
Dexcom replaces hand-held CGM receivers after missed audio alerts
Jun 17, 2025 10:40am
Dexcom wins FDA clearance for 15-day G7 CGM sensor
Apr 10, 2025 11:31am
